News
Tax in the news – impacts on biotech and tech companies
Latest tax updates
F-Star collaboration
As announced today (May 31), Confluence Tax is delighted to have assisted F-star on the acquisition of the asset-centric vehicle F-Star Gamma by Denali Therapeutics, leveraging F-star’s Modular Antibody Technology™ beyond immuno-oncology. Read the full press release here.
BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?
THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…
Finalist in Tolley’s Taxation Awards 2018 – Confluence Tax
CONFLUENCE Tax is delighted to announce the team has been shortlisted in the Tolley’s Taxation Awards 2018. The team is a finalist in the category Best Independent Consultancy Firm and is the smallest company to be selected. ‘It’s fantastic to be chosen as a finalist, especially as it’s the first time we’ve applied for an award.…
HMRC Enterprise Centre: why the delays?
IN LIGHT of the November 2017 budget where the Chancellor announced the importance of supporting the R&D sector and growth of small businesses, why are we experiencing delays at the HMRC Enterprise Centre? Confluence Tax’s Anne-Marie Rickels looks at the problems and what can be done. Venture Capital Schemes, such as VCT, EIS and SEIS,…
BUDGET 2017: BEST BITS
CONFLUENCE TAX held a post-budget tax briefing for those in the biotech and tech space on November 23, 2017. Here we’ve shared the ‘need to knows’ for all knowledge-intensive companies and investors WHILE MANY commentators on the autumn budget were unmoved, we welcomed various tax changes that affect the knowledge-based businesses we work with –…
Budget 2017 tax predictions: EIS, SEIS and VCT relief
SWEEPING aside the Chancellor’s big challenges of income tax rates, self-employed vs employed workers and the headache of the gig economy, an area of tax with direct relevance to technology and biotechnology companies that I believe is ripe for change in the 2017 budget is venture capital schemes – EIS, SEIS and VCT relief. These…
Confluence Tax and Dutch firm Asjes Bisseling form strategic alliance
Clients to benefit from expanded tax advice network across Europe UK BASED specialist tax advisory firm Confluence Tax and Netherlands-based AsjesBisseling have formed a strategic alliance that will benefit clients across Europe. Confluence Tax is the only tax advisory firm in the UK to specialise in advising biotechnology and…
Autumn 2017 post-budget tax briefing
You are invited… to the essential Autumn 2017 post-budget tax briefing for biotech and tech companies Key points distilled, digested and presented by the tax experts at Confluence Tax – we’ve done the hard work for you! We would be delighted if you could join us on November 23, 2017 in the Cambridge Building, Babraham…
Pet tech – an investment opportunity not to be sniffed at
Guest blog by Emma Dahm, Red Horse Digital THERE’S no doubt pet tech has an extremely bright future. We pet owners are spending more on our companions than ever before. To some degree this is led by our increasing emotional attachment – even dependence – on our cats and dogs for companionship, entertainment, fitness and…
Share schemes tax summary
THESE SHARE SCHEMES TABLES summarise the respective tax treatments of the three most common ways of providing equity reward to UK tax resident employees.